Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1502.4000 -11.40 (-0.75%)
NSE Jun 27, 2025 15:31 PM
Volume: 1.9M
 

logo
Cipla Ltd.
edited 03 Nov 2021
1502.40
-0.75%
Cipla unit gets notice from US firm for termination of acquisition deal
Cipla unit gets notice from US firm for termination of acquisition deal
Moneycontrol
In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million (around Rs 1,560 crore).
Cipla Ltd. is trading above its 150 day SMA of 1479.5
Cipla unit gets notice from US firm for termination of acquisition deal
Business Standard | 03 Nov 2021
More from Cipla Ltd.
Recommended
Five Interesting Stocks Today - June 27, 2025
The Baseline | 27 Jun 2025, 05:49PM
Market closes higher, Ahluwalia bags Rs 1,103.6 crore residential projects in Gurugram and Bengaluru
Trendlyne Marketwatch | 27 Jun 2025, 03:57PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
| 20 May 2022